Supplementary Figure from Preclinical Development of the Class-I–Selective Histone Deacetylase Inhibitor OKI-179 for the Treatment of Solid Tumors

Authors:
  • JDJennifer R. Diamond
    Jennifer R. Diamond
  • TPTodd M. Pitts
    Todd M. Pitts
  • DUDana Ungermannova
    Dana Ungermannova
  • GZGan Zhang
    Gan Zhang
  • APAndrew J. Phillips
    Andrew J. Phillips
  • SBStacey M. Bagby
    Stacey M. Bagby
  • JPJessica Pafford
    Jessica Pafford
  • BYBetelehem W. Yacob
    Betelehem W. Yacob
  • TNTimothy P. Newton
    Timothy P. Newton
  • JTJohn J. Tentler
    John J. Tentler

Abstract
Supplementary Figure from Preclinical Development of the Class-I–Selective Histone Deacetylase Inhibitor OKI-179 for the Treatment of Solid Tumors